Long-acting	JJ	long-acting JJ PennPOS
human	JJ	human JJ PennPOS
serum	NN	serum NN PennPOS
albumin-thioredoxin	NN	albumin-thioredoxin NN PennPOS
fusion	NN	fusion NN PennPOS
protein	NN	protein NN PennPOS
suppresses	VBZ	suppress VBZ PennPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
progression	NN	progression NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
thought	VBN	think VBN PennPOS
to	TO	to p-acp NUPOS
involve	VB	involve VBP PennPOS
inflammatory	JJ	inflammatory JJ PennPOS
cells	NNS	cell NNS PennPOS
and	CC	and cc NUPOS
reactive	JJ	reactive JJ PennPOS
oxygen	NN	oxygen NN PennPOS
species	NNS	specie NNS PennPOS
(	(	( ( NUPOS
ROS	NN	ros NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
superoxide	NN	superoxide NN PennPOS
anion	NN	anion NN PennPOS
radical	NN	radical NN PennPOS
(	(	( ( NUPOS
O2	CD	o2 CD PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
)	)	) ) NUPOS
.	.	. . NUPOS

There	EX	there pc-acp NUPOS
is	VBZ	be vbz NUPOS
currently	RB	current av-j NUPOS
no	DT	no dx NUPOS
effective	JJ	effective JJ PennPOS
treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
previously	RB	previous av-j NUPOS
developed	VBD	develop VBD PennPOS
a	DT	a dt NUPOS
human	JJ	human JJ PennPOS
serum	NN	serum NN PennPOS
albumin	NN	albumin NN PennPOS
(	(	( ( NUPOS
HSA	NN	HSA NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
thioredoxin	NN	thioredoxin NN PennPOS
1	CD	1 crd NUPOS
(	(	( ( NUPOS
Trx	NN	trx NN PennPOS
)	)	) ) NUPOS
fusion	NN	fusion NN PennPOS
protein	NN	protein NN PennPOS
(	(	( ( NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
)	)	) ) NUPOS
designed	VBN	design VBN PennPOS
to	TO	to p-acp NUPOS
overcome	VB	overcome VBN PennPOS
the	DT	the dt NUPOS
unfavorable	JJ	unfavorable JJ PennPOS
pharmacokinetic	JJ	pharmacokinetic JJ PennPOS
and	CC	and cc NUPOS
short	JJ	short JJ PennPOS
pharmacological	JJ	pharmacological JJ PennPOS
properties	NNS	property NNS PennPOS
of	IN	of pp-f NUPOS
Trx	NN	trx NN PennPOS
,	,	, , NUPOS
an	DT	a dt NUPOS
antioxidative	JJ	antioxidative JJ PennPOS
and	CC	and cc NUPOS
anti-inflammatory	JJ	anti-inflammatory JJ PennPOS
protein	NN	protein NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
this	DT	this d NUPOS
study	NN	study NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
examined	VBD	examine VBD PennPOS
the	DT	the dt NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
effect	NN	effect NN PennPOS
of	IN	of pp-f NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
on	IN	on IN PennPOS
an	DT	a dt NUPOS
IPF	NN	IPF NN PennPOS
animal	NN	animal NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
bleomycin	NN	bleomycin NN PennPOS
(	(	( ( NUPOS
BLM	NN	Blm NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
induced	VBN	induce VBN PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

A	DT	a dt NUPOS
pharmacokinetic	JJ	pharmacokinetic JJ PennPOS
study	NN	study NN PennPOS
of	IN	of pp-f NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
or	CC	or cc NUPOS
Trx	NN	trx NN PennPOS
in	IN	in IN PennPOS
BLM	NNP	Blm NN PennPOS
mice	NNS	mouse n2 NUPOS
showed	VBD	show VBN PennPOS
that	IN	that cst NUPOS
the	DT	the dt NUPOS
plasma	NN	plasma NN PennPOS
retention	NN	retention NN PennPOS
and	CC	and cc NUPOS
lung	NN	lung NN PennPOS
distribution	NN	distribution NN PennPOS
of	IN	of pp-f NUPOS
Trxc	NN	Trxc NN PennPOS
was	VBD	be vbd NUPOS
markedly	RB	marked RB PennPOS
improved	VBN	improve VBN PennPOS
by	IN	by IN PennPOS
fusion	NN	fusion NN PennPOS
with	IN	with pp NUPOS
HSA	NN	HSA NN PennPOS
.	.	. . NUPOS

A	DT	a dt NUPOS
weekly	JJ	weekly JJ PennPOS
intravenous	JJ	intravenous JJ PennPOS
administration	NN	administration NN PennPOS
of	IN	of pp-f NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
not	RB	not xx NUPOS
Trx	NN	trx NN PennPOS
,	,	, , NUPOS
ameliorated	VBN	ameliorate VBN PennPOS
BLM-induced	JJ	blm-induced JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
,	,	, , NUPOS
as	IN	as c-acp NUPOS
evidenced	VBN	evidence VBN PennPOS
by	IN	by IN PennPOS
a	DT	a dt NUPOS
histopathological	JJ	histopathological JJ PennPOS
analysis	NN	analysis NN PennPOS
and	CC	and cc NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
hydroxyproline	NN	hydroxyproline NN PennPOS
levels	NNS	level NNS PennPOS
.	.	. . NUPOS

HSA-Trx	NN	HSA-Trx NN PennPOS
suppressed	VBD	suppress VBD PennPOS
active-transforming	JJ	active-transforming JJ PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
TGF	NN	tgf NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
b	NN	b NN PennPOS
levels	NNS	level NNS PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
and	CC	and cc NUPOS
inhibited	VBD	inhibit VBD PennPOS
the	DT	the dt NUPOS
increase	NN	increase NN PennPOS
of	IN	of pp-f NUPOS
inflammatory	JJ	inflammatory JJ PennPOS
cells	NNS	cell NNS PennPOS
in	IN	in IN PennPOS
bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
fluid	NN	fluid NN PennPOS
,	,	, , NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
inflammatory	JJ	inflammatory JJ PennPOS
cytokines	NNS	cytokine NNS PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
oxidative	JJ	oxidative JJ PennPOS
stress	NN	stress NN PennPOS
markers	NNS	marker NNS PennPOS
.	.	. . NUPOS

An	DT	a dt NUPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
EPR	NN	EPR NN PennPOS
experiment	NN	experiment NN PennPOS
using	VBG	use VBG PennPOS
phosphate-buffered	JJ	phosphate-buffered JJ PennPOS
saline-stimulated	JJ	saline-stimulated JJ PennPOS
neutrophils	NNS	neutrophil NNS PennPOS
confirmed	VBD	confirm VBD PennPOS
the	DT	the dt NUPOS
O2	CD	o2 CD PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
scavenging	NN	scavenging NN PennPOS
ability	NN	ability NN PennPOS
of	IN	of pp-f NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
.	.	. . NUPOS

Furthermore	RB	furthermore av NUPOS
,	,	, , NUPOS
post-treatment	JJ	post-treatment JJ PennPOS
of	IN	of pp-f NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
had	VBD	have vhd NUPOS
a	DT	a dt NUPOS
suppressive	JJ	suppressive JJ PennPOS
effect	NN	effect NN PennPOS
against	IN	against pp NUPOS
BLM-induced	JJ	blm-induced JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
results	NNS	result NNS PennPOS
suggest	VBP	suggest VBP PennPOS
that	IN	that cst NUPOS
HSA-Trx	NN	HSA-Trx NN PennPOS
has	VBZ	have vdz NUPOS
potential	JJ	potential JJ PennPOS
as	IN	as c-acp NUPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
agent	NN	agent NN PennPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
because	IN	because c-acp NUPOS
of	IN	of pp-f NUPOS
its	PRP$	its po31 NUPOS
long-acting	JJ	long-acting JJ PennPOS
antioxidative	JJ	antioxidative JJ PennPOS
and	CC	and cc NUPOS
anti-inflammatory	JJ	anti-inflammatory JJ PennPOS
modulation	NN	modulation NN PennPOS
effects	NNS	effect NNS PennPOS
.	.	. . NUPOS

